Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Explore the unique financial literacy challenges women face and how to overcome them. Empower your financial journey with vital insights.
28,655 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
A March 2026 market backdrop pushes index fund investing to the forefront as brokers compete on fees, access to major...
A billionaire hedge fund manager shows the power of high-conviction bets in AI. This article breaks down Ackman'...
Wolfspeed has bounced on recent news, but deep profitability and liquidity issues linger. This guide breaks down the ...
Johnson & Johnson and AbbVie report strong Q1 2026 results, showcasing two contrasting growth paths as biosimilar cha...
Investors face a pivotal choice: put $10,000 into Nvidia's AI compute surge or Meta's ad-driven AI expansion. Here's ...
Joby Aviation is transitioning from test flights to revenue growth, with 2026 guidance anchoring the stock as investo...
CoreWeave unleashed resilient US-scale growth with a massive backlog, while Nebius posted stronger margins on a small...
Borrowers with a 600 credit score face tighter lending, but flexible programs from a handful of lenders are expanding...
A 65-agent Texas team leaves Fathom Realty to join The Real Brokerage, citing technology and revenue sharing as key d...
March 2026 sees renewed volatility in energy and metals markets, prompting traders to reevaluate their platforms. Thi...
The U.S. Department of Housing and Urban Development has opened a Fair Housing Act investigation into Washington stat...